EyeGate Pharmaceuticals I...

NASDAQ: EYEG · Real-Time Price · USD
35.64
-0.07 (-0.20%)
At close: Aug 19, 2025, 3:59 PM
35.69
0.13%
After-hours: Aug 19, 2025, 04:04 PM EDT

EyeGate Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-2.19M 12.44M -3.41M -2.97M -2.47M -2.58M
Depreciation & Amortization
318.00 16.34K -20.8K 11.06K 12.6K 10.6K
Stock-Based Compensation
148.62K 73.06K 171.18K 149.47K 262.89K 216.94K
Other Working Capital
n/a -6.17M -301.87K 6.8M -325.44K 5.51M
Other Non-Cash Items
n/a 8.48M 2.45M -6.4M 46.9K -5.74M
Deferred Income Tax
n/a -288.75K n/a n/a n/a n/a
Change in Working Capital
n/a -8.18M 1.74M 6.93M -490.47K 5.53M
Operating Cash Flow
-2.7M 12.55M 920.06K -2.27M -2.64M -2.57M
Capital Expenditures
n/a -510 n/a n/a -5.75K -58.12K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
-3.62M -27.83M -7.8M n/a n/a n/a
Sales Maturities Of Investments
6.29M 7.09M 5.88M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
2.67M -20.74M -1.92M n/a -5.75K -58.12K
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -9.48M n/a 9.76M -278.19K 8.04M
Financial Cash Flow
n/a 6.02M n/a 9.76M -278.19K 8.04M
Net Cash Flow
-21.27K -1.85M -933.86K 7.44M -2.95M 5.42M
Free Cash Flow
-2.7M 12.55M 920.06K -2.27M -2.64M -2.63M